Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 62.02B | 64.88B | 53.30B | 45.95B | 36.51B | 30.93B |
Gross Profit | 20.04B | 20.55B | 18.20B | 16.37B | 12.46B | 11.22B |
EBITDA | 8.63B | 9.38B | 8.19B | 7.50B | 5.69B | 5.16B |
Net Income | 4.09B | 4.06B | 3.54B | 2.95B | 2.37B | 2.30B |
Balance Sheet | ||||||
Total Assets | 101.66B | 105.44B | 85.76B | 65.69B | 52.50B | 40.00B |
Cash, Cash Equivalents and Short-Term Investments | 25.64B | 27.33B | 27.27B | 20.07B | 18.16B | 14.63B |
Total Debt | 5.89B | 5.60B | 4.17B | 4.65B | 3.50B | 4.62B |
Total Liabilities | 72.59B | 75.44B | 58.71B | 41.77B | 32.30B | 23.64B |
Stockholders Equity | 23.53B | 24.21B | 21.74B | 18.97B | 17.02B | 14.84B |
Cash Flow | ||||||
Free Cash Flow | 11.64B | 6.15B | 7.97B | 4.75B | 4.73B | 2.88B |
Operating Cash Flow | 11.92B | 6.84B | 8.98B | 6.35B | 5.28B | 3.52B |
Investing Cash Flow | -1.16B | -5.96B | -1.94B | -3.13B | 195.69M | -841.31M |
Financing Cash Flow | -245.77M | -799.03M | 147.56M | -1.30B | -1.96B | -1.79B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥89.85B | 17.42 | 2.05% | 7.17% | 45.75% | ||
76 Outperform | $86.04B | 21.41 | 17.46% | 1.85% | 21.72% | 14.51% | |
63 Neutral | £507.76M | 24.89 | -8.56% | 178.98% | 4.03% | -28.20% | |
$436.27M | 13.42 | 14.89% | 0.02% | ― | ― | ||
67 Neutral | ¥72.19B | 19.55 | 3.51% | -0.93% | -37.97% | ||
¥82.60B | 10.49 | 1.28% | ― | ― | |||
79 Outperform | ¥88.31B | 14.73 | 2.33% | 12.92% | 11.14% |